BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS

钾离子通道作为麻醉目标的背景

基本信息

  • 批准号:
    6181120
  • 负责人:
  • 金额:
    $ 23.15万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    1998
  • 资助国家:
    美国
  • 起止时间:
    1998-09-30 至 2001-09-02
  • 项目状态:
    已结题

项目摘要

Although it has been known for more than 150 years that volatile anesthetics produce central nervous system (CNS) depression in numerous species, the basic mechanisms underlying anesthetic action are not yet understood. We hypothesize that volatile anesthetics induce neuronal inhibition primarily by activating a discrete class of potassium (K+) channels responsible for background currents (also known as baseline or leak currents). We have shown that in neurons of the mollusc Aplysia californica, volatile anesthetics increase the open probability of an outwardly rectifying background K+ channel (S-K channel), resulting in neuronal hyperpolarization and silencing of spontaneous action potentials. A recently discovered class of K+ channels, distinguished by having two putative pore-forming sequences tandemly arrayed within their primary amino acid sequence, appears to mediate background currents. We found that the function of the prototypic member of this family, a yeast outwardly rectifying background channel (TOK1) is potentiated by volatile anesthetics. TOK1 potentiation obeys the rank order of clinical potency halothane greater than isoflurane greater than desflurane), overlaps the clinical range, does not occur with non- anesthetics and is stereospecific [S(+) greater than R(-)-isoflurane]. We also have preliminary evidence for the presence of volatile anesthetic-stimulated baseline K+ channels in mammalian brain (rat cerebellar granule cells). We now propose the continuation of these studies by cloning and expressing new members of the tandem pore K+ channel family for studies of their sensitivity to volatile anesthetics. The proposed studies are important from three perspectives: 1) they have the potential for elucidating a molecular mechanism of volatile anesthetic action; 2) they will lead to a greater understanding of the role of background channels in CNS activity; 3) they may provide targets for the development of more specific anesthetic agents.
尽管人们在150多年前就知道这种挥发性 麻醉药在许多情况下引起中枢神经系统(CNS)抑制 物种,麻醉作用的基本机制还不是很清楚 明白了。我们假设挥发性麻醉剂诱导神经元 主要通过激活一类不连续的钾(K+)来抑制 负责背景电流的通道(也称为基线或 泄漏电流)。我们已经证明,在软体动物海兔的神经元中 加州,挥发性麻醉剂增加开放的概率 向外整流背景K+通道(S-K通道),导致 神经元超极化与自发动作的沉默 潜力。最近发现的一类K+通道,区别于 通过在内部排列两个假定的成孔序列 它们的主要氨基酸序列似乎是背景的中介 洋流。我们发现这个原型成员的功能 家族,一个酵母外向整流背景通道(TOK1)是 被挥发性麻醉剂强化了。TOK1增强服从等级 临床效价等级氟烷大于异氟醚大于 地氟醚),与临床范围重叠,不会发生在非 麻醉药物,立体特异性[S(+)大于R(-)-异氟烷]。 我们也有初步证据证明挥发性物质的存在 麻醉刺激哺乳动物(大鼠)脑内基础K+通道 小脑颗粒细胞)。我们现在建议继续实施这些措施 串联孔K+新成员的克隆与表达研究 通道家族,用于研究他们对挥发性麻醉药的敏感性。 拟议的研究从三个角度来看是重要的:1)它们具有 阐明挥发性疾病分子机制的可能性 麻醉作用;2)它们将使人们更好地理解 背景通道在中枢神经系统活动中的作用;3)它们可能提供靶点 用于开发更具体的麻醉剂。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

CHARLES S YOST其他文献

CHARLES S YOST的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('CHARLES S YOST', 18)}}的其他基金

BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
  • 批准号:
    2686327
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
  • 批准号:
    6019491
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
POTASSIUM CHANNEL ACTIVATION BY VOLATILE ANESTHETICS
挥发性麻醉剂激活钾通道
  • 批准号:
    6519882
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
POTASSIUM CHANNEL ACTIVATION BY VOLATILE ANESTHETICS
挥发性麻醉剂激活钾通道
  • 批准号:
    6386892
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
  • 批准号:
    7193518
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
BACKGROUND POTASSIUM CHANNELS AS ANESTHETIC TARGETS
钾离子通道作为麻醉目标的背景
  • 批准号:
    2909120
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
  • 批准号:
    6525464
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
  • 批准号:
    7031283
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
  • 批准号:
    6370601
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:
Background Potassium Channels as Anesthetic Targets
作为麻醉目标的背景钾通道
  • 批准号:
    6651987
  • 财政年份:
    1998
  • 资助金额:
    $ 23.15万
  • 项目类别:

相似海外基金

Investigation of the mechanism of recovery effect of anesthetics on endothelial glycocalyx damage
麻醉药对内皮糖萼损伤恢复作用的机制探讨
  • 批准号:
    23K08341
  • 财政年份:
    2023
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Elucidation of a Novel Functional Mechanism of Intravenous Anesthetics Based on the Membrane Lipid Theory and Its Application to Clinical Practice
基于膜脂理论的静脉麻醉药新作用机制的阐明及其在临床实践中的应用
  • 批准号:
    23K06361
  • 财政年份:
    2023
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
  • 批准号:
    10657509
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Electrophysiological analysis of proarrhythmic properties of volatile anesthetics using an originally developed arrhythmogenic model
使用最初开发的致心律失常模型对挥发性麻醉药的致心律失常特性进行电生理分析
  • 批准号:
    22K09032
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Modification of the intercellular network of immune cells in tumor microenvironment by sedatives and anesthetics.
通过镇静剂和麻醉剂改变肿瘤微环境中免疫细胞的细胞间网络。
  • 批准号:
    22K09083
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
The role of astrocytes in emergence from volatile anesthetics
星形胶质细胞在挥发性麻醉剂苏醒中的作用
  • 批准号:
    10340339
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Mechanisms and blood-based biomarkers of intergenerational neurobehavioral effects of general anesthetics
全身麻醉药代际神经行为效应的机制和血液生物标志物
  • 批准号:
    10538703
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Disruptions in the brain reward system through postnatal exposure to GABA agonists and anesthetics
产后接触 GABA 激动剂和麻醉剂会扰乱大脑奖励系统
  • 批准号:
    10440005
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10870632
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
对麻醉药的神经生理学抵抗力低是临床前/前驱阿尔茨海默病和神经血管病理学、谵妄风险和注意力不集中的标志
  • 批准号:
    10671023
  • 财政年份:
    2022
  • 资助金额:
    $ 23.15万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了